Pork CRC Options Extended by 12 Months
Pork CRC Options Extended by 12 Months
Brisbane, Sep 13, 2017 AEST (ABN Newswire) - Anatara Lifesciences Limited (ASX:ANR) has today undertaken to extend by 12 months the expiry date of 250,000 Options which Anatara issued to the Pork Cooperative Research Centre (CRC) in 2015.

The Options were originally issued to the Pork CRC on 18th September 2015, with an exercise price of $0.50 and expiry of 18th September 2017. A new expiry date of 18th September 2018 has now been set at the original exercise price.

Anatara Chairman and CEO, Dr Mel Bridges said, "The Pork CRC is an important and strategic relationship for Anatara and extending the Option period will enable us to provide the CRC with further incentive to share in the upside of Anatara's commercial success."

The relationship with the Pork CRC enables Anatara to work closely with key players in the Australian pork industry. Active partners and participants in the CRC include the largest Australian pork producers, feed manufacturers, key government and farmer industry bodies, including the CSIRO.

About Anatara Lifesciences Ltd

Anatara Lifesciences ASX ANRAnatara Lifesciences (ASX:ANR) develops and aims to partner non-antibiotic, oral products for gastrointestinal diseases in animals and humans where there is significant unmet need and large market opportunity. In May 2018, Anatara granted an exclusive licence to the leading global animal health company, Zoetis Inc., for the worldwide development, manufacturing, distribution and marketing of its lead product Detach as a non-antibiotic approach to aid in the control of diarrhoeal disease (known as scour) in livestock and in horses. Anatara is now focused on developing its human product pipeline for gastrointestinal health applications. For more information, please visit www.anataralifesciences.com.



Investor inquiries:
Dr Mel Bridges
Chairman & CEO
Anatara Lifesciences
Phone: +61-413-051-600
Email: mbridges@anataralifesciences.com

Media inquiries:
Jane Lowe
IR Department
Phone: +61-411-117-774
Email: jane.lowe@irdepartment.com.au

Related Companies

Anatara Lifesciences Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 51) (Last 30 Days: 128) (Since Published: 3092) 

Anatara Lifesciences Ltd NEWS: RECENT VISITS (5361)

Research Report

Social Media